Philip Morris
Therapie Woche Forschung Fortbilding Fortschritt
Fields
- Author
- Karlsruhe, G.B.
- Type
- ADVE, ADVERTISEMENT
- Master ID
- 2063628473/8882
- 2063628473-8882 Book 52 Tab Number 1 - 60 Low Tar and Disease
- 2063628478-8480 Less Harmful Ways of Smoking A Workshop of the Second World Conference on Smoking and Health Held in London, England 710920 - 710924
- 2063628482-8483 Introduction Working Party on Less Harmful Ways of Smoking
- 2063628485-8487 Smoking and Health: Looking Back - and Ahead
- 2063628493-8497 Realistic Goals for Smoking and Health A Case for Safer Smoking
- 2063628499-8502 Cause and Prevention of Lung Cancer
- 2063628504-8505 Safer Cigarettes
- 2063628507 Safer Cigarettes
- 2063628509-8510 the Tenth Anniversary of the Surgeon General's Report on Smoking and Health: Have We Made Any Progress?
- 2063628516-8522 Proceedings Xi International Cancer Congress Florence 740000 Volume 3 Cancer Epidemiology Environmental Factors
- 2063628524-8530 Smoking and Disease: the Evidence Reviewed
- 2063628534-8535 Biology and Prevention of Smoking Related Diseases
- 2063628539-8544 Toward the Prevention of Cancer. Geographic Clues to High-Risk Groups in Cancer
- 2063628546-8553 Cultural and Behavioral Aspects of Risk Factors: Society's Obligation
- 2063628555-8571 Tobacco Carcinogenesis
- 2063628573-8587 Prevention and Detection of Cancer Part I. Prevention Volume 1. Etiology
- 2063628589-8591 Head and Neck Cancer. State of the Art Conference 760216, 760217, 760218, the Royal Orleans, New Orleans, Louisiana. Smoking and Health Program Activities.
- 2063628593-8597 Toward Less Hazardous Cigarettes Current Advances
- 2063628599 Toward Less Hazardous Cigarettes
- 2063628603-8605 How Safe Can Cigarettes Be?
- 2063628607-8611 Controlling the Smoking Epidemic
- 2063628617-8618 Switch to Low Tar-Nicotine If Smokers Can't Quit
- 2063628619
- 2063628621-8626 'defused' Cigarettes - Slogan or Reality?
- 2063628628-8636 the Changing Histopathology of Lung Cancer A Review of 1682 Cases
- 2063628640-8654 Recent Advances in Community Medicine
- 2063628656-8657 News and Notes
- 2063628660-8667 Rauchen Und Gesunheit Die Epidemiology Tabakbedingter Erkrankungen
- 2063628669-8670 Comment on the Hunter Committee's Second Report
- 2063628672-8675 Priorities in Cancer Prevention: A Conference Appraisal
- 2063628677-8678 Banbury Report A Safe Cigarette?
- 2063628680-8690 Banbury Report A Safe Cigarette?
- 2063628692-8697 the Long-Term Benefits of Reducing Tar and Nicotine in Cigarettes
- 2063628699-8711 Banbury Report A Safe Cigarette?
- 2063628713-8721 Banbury Report A Safe Cigarette?
- 2063628723 A Safe Cigarette ?
- 2063628724-8732 Carcinogens, Cocarcinogens, and Tumor Inhibitors in Cigarette Smoke Condensate
- 2063628733-8739 A Summary Appraisal
- 2063628741-8748 A Summary Appraisal
- 2063628750-8757 Priority and Choice of Goals - Stopping Completely Vs Less Harmful Ways of Smoking
- 2063628759-8769 Observed No - Effect Thresholds and the Definition of Less Hazardous Cigarettes
- 2063628771-8785 Banbury Report A Safe Cigarette? Changes in Bronchial Epithelium: Then and Now
- 2063628787-8808 Risk-Reduction Achievements and Future Directions
- 2063628810-8820 Modification Through Agricultural Techniques for Developing A Safer Tobacco
- 2063628824-8826 Trends in Tar, Nicotine, and Carbon Monoxide Yields of Uk Cigarettes Manufactured Since 340000
- 2063628830-8837 Smoking and Arterial Disease
- 2063628839-8844 the Tobacco Industry in Transition Policies for the 800000s
- 2063628847-8861 Avoidable Risks of Cancer in the U.S.
- 2063628863-8873 Smoking Psychology and Pharmacology
- 2063628877-8879 Trends in Lung Cancer Mortality
Related Documents:
Document Images
;Erfolgreiche
Tfanskutan Therapie
'
~
Venenleiden Verletzungen
Vernarbungen
Drei WirkstoHe penetrieren
''s in den Kapillarbereich der Haut:
Hochdosiertes natives Heparin
+ Allantoin + Dexpanthenol
Hepathrombiri;i
50000
Salbe
Initial sowie fiir schwerere
und rezidivierende Falle
Zueammenseliung: HEPATHRGMBINe'-511000-SALBE:100, enth.: Heparin 5000D I.E., Allanloin 300 mg,
Dexpanlheno140D mg.
AnwenEUngsgehlete:BeiveriktisemSympromenkOmplex.Thramboph!ebilis,posNVCmbrnischem5yndrorn.Varizen.Wa
denkrampfen.Ulcuscmns. -
Bei Spod-und Unfallvorletrungon (Hamatamen, Prellungen, Dislorsienen). Bei Bursitis, Tnndovaglnitis,
Oupuylren scter KonlrakW4 Narbenkontraklur.
GegenanzelOen:BesleM1ennachde2eitigernWissensslandnicM.Nebenwirkungen:SindbishernicMbeobacMelworden.
ADENYLCHEMIEGMBH~1e00BERLIN10
WirXungswelse: Nazives Heparin wirhl enlzlindungshemmend anlilhrombolisch, durchb!ulungsldrdernd und
entslauend .
Allantoin wirkl penetralionslbrdemd, zallpro!iferationsaoregend und furdert Stoffwechselvnrgange.
Dsvpanlhenpl wirktwundheilend, granu!alions-und epilhelisalienstdrdernd.
Daslerung: HEPATHROMBIN^-5e000-SALBE nach Bedarl mehrmals I2glich aullmgen, evenluell Balbenverband
an!egeo.
Handelsfarmen und Praise: Tube m1140 g OM 15,70. Tube mit 100 g DM 3),08. AnsIallSpackung. AII¢
Prelse m. MwSt
AOENYLC'',. _GMBH1OOOBERLIN1O
:9
c4c.~=NUaris»_
JAHRGANG 19.DEZdi:1Rr 91?!79.
G
~
i-
~
A399T/0 StandAug.99i
i31lAUN. H Rt-9-, IJHE
